The Second Nikkei Asian Conference:Renewal of Our Commitment to Fight against Communicable Diseases

Okinawa Communicable Diseases Statement 2015 PDF Download

Nikkei Asian Review Nikkei Communicable Disease Conference 2015

The 2nd Nikkei Asian Conference digest(Movie)

The 2nd Nikkei Asian Conference: Renewal of Our Commitment to Fight against Communicable Diseases
Toward Developing a Specific Action Plan

Epidemic of dengue fever in the Ebola hemorrhagic fever and Japan in the world scale spreading demonstrated that communicable disease can spread rapidly and present simultaneously around the world as a result of increasing and accelerating population migration and physical distribution transactions. Is not limited to this, in all communicable disease not only cause health problems but also lead to stagnation and cessation of business activities, thereby significantly affecting the social economy.
To minimize damage caused by these infections, drastic measures toward prevention should be implemented both domestically and through international cooperation.
Recognizing this, Nikkei Inc. and Nikkei Business Publications, Inc. held the 1st "Nikkei Asian Conference: Renewal of Our Commitment to Fight against Communicable Diseases" in February 2014 in Okinawa, a hub city in Asia. All stakeholders in industry, government and academia were invited, including government agencies, organizations and academic societies involved in infection prevention in Japan and abroad. At the conference, participants reached an understanding that infectious diseases in Asia is one of the major risks affecting economic growth and people’s health in the region that urgently needs to be addressed. Based on this understanding, all participants agreed on the "Okinawa Communicable Diseases Statement 2014."
The statement expresses that Japan, which has extensive experience and human resources in infection prevention, public health and healthcare innovation, is expected to make further contributions. The statement also confirmed that, in view of its experience in eliminating filariasis and malaria as well as its geopolitical characteristics, Okinawa is expected to contribute at the forefront to further strengthen cooperation between Japan and other Asian countries and to serve as a center in Asia for infection prevention.
The 2nd Nikkei Asian Conference will be held with the aim of deepening the discussions that were held at the first conference in order to enhance cooperation and develop a more specific action plan.

In the 2nd conference, a specific action plan to address actions that Japan is expected to take as specified in the Okinawa Communicable Diseases Statement 2014 will be developed in cooperation with stakeholders participating from Japan and abroad. Discussions will continue until an implementation plan is developed, which will be presented in the "Okinawa Communicable Diseases Statement 2015." As with the 2014 statement, the 2015 statement will be widely disseminated in Japan and other countries in the Asian region to promote the importance of preventing infections and the necessity of cooperation in the Asian region so as to ensure Japan’s leadership in infection prevention.

Conference OverView

Date
January 16 (Fri) 2015  8:55~21:00 (Doors open at 8:30)
January 17 (Sat) 2015  9:00~14:30 (Doors open at 8:30)
Venue
Okinawa Bankoku Shinryokan
1792 Kise, Nago-shi, Okinawa, 905-0026
TEL: +81-980-53-3155
FAX: +81-980-53-3163
Organizer
Nikkei Inc., Nikkei Business Publications, Inc.
In association with
Okinawa Prefectural Government
Support
Ministry of Economy, Trade and Industry
Ministry of Education, Culture, Sports, Science and Technology
Ministry of Foreign Affairs
Ministry of Health, Labour and Welfare
Cosponsors
DAIICHI SANKYO COMPANY
FUJIFILM Corporation
TOYAMA CHEMICAL
KIRIN HOLDINGS
Mitsubishi Tanabe Pharma
NIPRO
Otsuka Pharmaceutical
SARAYA
SHIONOGI
Sumitomo Chemical
Sumitomo Dainippon Pharma
Global Health Innovative Technology Fund
Admission
Free admission: Participants will be selected by a draw. Pre-registration for the draw is required. Confirmation of your participation will be sent by email.

Program

January 16 (Fri) 2015

8:30

Doors open

8:55-9:00

Opening remarks

Kohei Osada
Nikkei Inc. Director
Nikkei Business Publications, Inc. President

9:00-9:10

Opening remarks

Mr. Isho Urasaki
Vice Governor of Okinawa

9:10-9:15

Opening remarks

Ryosuke Harada
Nikkei Inc.
Managing Executive Officer, Global Business

9:15-9:30

Keynote speech (1):

H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR

9:30-9:45

Keynote speech (2):

Toward an Action Plan

Dr. Nu Nu Tha, Advisor to the President Health Sector. Advisor Office of the President. REPUBLIC OF THE UNION OF MYANMAR

9:45-10:05

Keynote speech (3):

WHO nosocomial infection prevention campaign
Clean Care is Safer Care – Action Plan
~World Health Organization 1st Global Patient Safety Challenge~

Prof. Didier Pittet, MD, MS Director, Infection Control Programme, WHO Collaborating Centre on Patient Safety University of Geneva Hospitals, Switzerland, Programme Lead, WHO First Global Patient Safety Challenge: Clean Care is Safer Care

Profile

10:05-10:25

Keynote speech (4):

Possible to end AIDS, TB and Malaria? - Challenge of The Global Fund -

Prof. Osamu Kunii, MD, MPH, PhD, Head, Strategy, Investment and Impact Division,The Global Fund to Fight AIDS, Tuberculosis and Malaria

Profile

10:25-10:35

Break

10:35-10:45

Opening remarks

"Objectives and orientation of the Second Nikkei Asian Conference: Renewal of Our Commitment to Fight against Communicable Diseases"

  • <Chair> Dr. Shigeru Omi, MD, PhD, President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific

    Profile

  • <Co-Chair> Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization

    Profile

10:45-12:05

Panel Discussion I: "Current measures and issues of communicable diseases"
"WHO-driven measures against global and Asian communicable diseases"

"Current report on communicable diseases in Asian countries - what issues should be solved through collaboration with Japan?"

<Panelists>
  • Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization

    Profile

  • H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR

  • Dr. George Fu Gao, DPhil, MSc Institute of Microbiology, Chinese Academy of Sciences China CDC

  • Dr. Supamit Chunsuttiwat, Department of Disease Control, Ministry of Public Health, Thailand

  • Dr. Masato Tashiro, MD, PhD, Former Director, Influenza Virus Research Center,
    National Institute of Infectious Diseases

    Profile

  • Dr. Sreng Bun, Deputy-Director Department of Communicable Disease Control Ministry of Health, Cambodia

    Profile

  • Dr. Norio Sugaya, MD, Dep. of Pediatrics, Dep. of Infection Control, Keiyu Hospital

  • Dr. Nguyen Tran Hien, MD, MPH, PhD,
    Director, National Institute of Hygiene and Epidemiology
    Hanoi, Vietnam
    Chairman, Department of Epidemiology, Hanoi Medical University

    Profile

  • Dr. Mohamad Subuh MPPM,
    Director General
    Directorate General Of Disease Control and Environment Health Department Minister Of Health, Republic of Indonesia

    Profile

<Moderator>

Prof. Hitoshi Oshitani, MD, PhD, Tohoku University Graduate School of Medicine Department of Virology

Profile

12:05-12:50

Lunch

12:50-14:20

Panel Discussion II-1: <<Tuberculosis control>>

<Global Measures against tuberculosis; Current status and issues.>

<Panelists>
  • Dr. Hiroshi Ishikawa
    Fellow,Medicinal Chemistry,
    Otsuka Pharmaceutical Co., Ltd.

    Profile

  • Dr. Yasuhiro Yasutomi, DVM, PhD, Director, Tsukuba Primate Research Center, Professor, Dept. of Mol. Exp. Med. National Institute of Biomedical InnovationMie University Graduate School of Medicine

    Profile

  • Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization

    Profile

  • Dr. Srihadi Agungpriyono, DVM, PhD, Dean Faculty of Veterinary Medicine, Bogor Agricultural University (IPB), Indonesia

    Profile

  • Dr. Mercy Ahun
    Special Representative for GAVI Eligible Countries

    Profile

  • Prof. Osamu Kunii, MD, MPH, PhD
    Head, Strategy, Investment and Impact Division, The Global Fund to Fight AIDS, Tuberculosis and Malaria

    Profile

  • Mr. Yasuyoshi Mori
    Manager, Biochemical Research Loboratory-II, Eiken Chemical Co.,Ltd.

    Profile

<Moderator>

Dr. Tadao Shimao, MD, PhD, Adviser, Japan Anti-Tuberculosis Association

Profile

14:20-14:30

Break

14:30-15:30

Sectional meeting (1): Technical Support for Vietnam and contribution for Asia via JICA presented by Daiichi Sankyo Company, Ltd .

<Panelists>
  • Dr. Fumihiko Takeshita, M.D., Ph.D.
    Senior Director
    Vaccine Business Strategy Department, Vaccine Business Intelligence Division, DAIICHI SANKYO CO. Ltd.

    Profile

  • Mr. Yoshiharu Yoneyama
    Deputy Director General, and Group Director for Health 1, Human Development Department, Japan International Cooperation Agency

    Profile

  • Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization

    Profile

  • Mitsuru Miyata, Executive Leader Writer, Nikkei Business Publications, Inc.

    Profile

  • Dr. Nobuhiko Okabe, MD, Ph.D.
    Director General, Kawasaki City Institute for Public Health

    Profile

  • Dr. Nguyen Tran Hien, MD, MPH, PhD,
    Director, National Institute of Hygiene and Epidemiology
    Hanoi, Vietnam
    Chairman, Department of Epidemiology, Hanoi Medical University

    Profile

  • Dr. Masahiko Kikuchi, Ph.D.
    Vice President, Vaccine Business Intelligence Division Vaccine Business Strategy Department in Daiichi Sankyo Co., Ltd.
    Member of the Board, Kitasato Daiichi Sankyo Vaccine Co., Ltd.
    Member of the Board (outside), Japan Vaccine Co., Ltd.

    Profile

  • Dr. Nguyen Dang Hien MD. PhD
    Director, Center for Research and Production of Vaccines and Biologicals (POLYVAC)

    Profile

<Moderator>

Dr. Norihito Ueda, MD, Ph.D.
Senior Director, Vaccine Business Strategy Department, Daiichi Sankyo (DS) & Head of R&D Division, Kitasato Daiichi Sankyo Vaccine (KDSV)

Profile

Sectional meeting (2): For international medical base formation of the infection measures Presented by Okinawa Prefectural Government

<Panelists>
  • Mr. Kiyoaki Gushiken
    Deputy Director General in charge of Planning Promotion
    Department of Planning
    Okinawa Prefectural Government

    Profile

  • Dr. Hideki Kuniyoshi
    Deputy Director General in charge of Health and Sanitation
    Department of Public Health and Medical Care
    Okinawa Prefectural Government

    Profile

  • Dr. Kuniaki Nerome, CEO, The Institute of Biological Resources

    Profile

<Commentator>

Mr. Direk Limmathurotsakul, MD DLSTMH PhD
Head of Microbiology Department, Mahidol-Oxford Tropical Medicine Research Unit (MORU) University, Thailand

Profile

<Moderator>

Prof. Jiro Fujita, MD, PhD, FCCP, Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus

Profile

15:30-16:30

Sectional meeting (3): Asean Patient Safety Challenge ~WHO "Clean Care is Safer Care" ~
Presented by Saraya Co., Ltd.

<Presenters>
  • Prof. Didier Pittet, MD, MS Director, Infection Control Programme, WHO Collaborating Centre on Patient Safety University of Geneva Hospitals, Switzerland, Programme Lead, WHO First Global Patient Safety Challenge: Clean Care is Safer Care

    Profile

  • H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR

  • Prof. Dr. Nwe Nwe Oo, Director General, Department of Health Planning, Ministry of Health, Myanmar

  • Mr.Yusuke Saraya,President, SARAYA Co., LTD

    Profile

<Moderator>

Mr. Yoshiharu Yoneyama
Deputy Director General, and Group Director for Health 1, Human Development Department, Japan International Cooperation Agency

Profile

Sectional meeting (4): Drug-resistance: Current status and countermeasures against it in Asia Presented by Shionogi & Co., Ltd.

<Panelists>
  • Dr. Yasuyoshi Ike MD. PhD.
    Extraordinary Professor, Department of Bacteriology, Gunma University Graduate School of Medicine
    Representative Director, Association for Education in Bacterial-Drug Resistance

    Profile

  • Prof. Zheng Bo Division of Infectious Diseases, Peking University First Hospital. The deputy director on academic committee of China antimicrobial resistance surveillance system

    Profile

  • Mr. Kasamatsu Yoshiharu
    Director, Head of Adequate Use of Anti-infective Agent Team Global Business Division
    SHIONOGI & CO., Ltd.

<Moderator>

Prof. Jiro Fujita, MD, PhD, FCCP, Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus

Profile

16:30-16:40

Break

16:40-18:10

Panel discussion II-2<<Tuberculosis control>>

Discussion on issues raised in panel discussion II-1
and to create road map for extermination of tuberculosis with of public sector and government sector collaboration.

<Moderator>

Dr. Yasuhiro Yasutomi, DVM, PhD, Director, Tsukuba Primate Research Center, Professor, Dept. of Mol. Exp. Med. National Institute of Biomedical InnovationMie University Graduate School of Medicine

Profile

<Discussants>
  • H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR

  • Dr. George Fu Gao, DPhil, MSc Institute of Microbiology, Chinese Academy of Sciences China CDC

  • Dr. Supamit Chunsuttiwat, Department of Disease Control, Ministry of Public Health, Thailand

  • Dr. Srihadi Agungpriyono, DVM, PhD, Dean Faculty of Veterinary Medicine, Bogor Agricultural University (IPB), Indonesia

    Profile

  • Dr. Mohamad Subuh MPPM,
    Director General
    Directorate General Of Disease Control and Environment Health Department Minister Of Health, Republic of Indonesia

    Profile

  • Dr. Sreng Bun, Deputy-Director Department of Communicable Disease Control Ministry of Health, Cambodia

    Profile

  • Dr. Mercy Ahun
    Special Representative for GAVI Eligible Countries.

    Profile

  • Dr. Sharon Chan, Head of Asia, Aeras,

    Profile

  • Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization

    Profile

  • Dr. Hajime Inoue, MD, MPH,
    Director, Infectious Disease Control Division, Ministry of Health, Labour and Welfare

    Profile

  • Dr. Hiroshi Ishikawa
    Fellow,Medicinal Chemistry,
    Otsuka Pharmaceutical Co., Ltd.

    Profile

  • Mr. Masuhiro Yoshitake,
    Executive Operating Officer, Global Project Leader of TB Projects, Otsuka Pharmaceutical Co.,Ltd.

    Profile

  • Mr. Hiroshi Yoshida
    Member of the Board, R&D, Nipro Co.

    Profile

  • Dr. Fumihiko Takeshita, M.D., Ph.D.
    Senior Director
    Vaccine Business Strategy Department, Vaccine Business Intelligence Division, DAIICHI SANKYO CO. Ltd.

    Profile

  • Mr. Yasuyoshi Mori
    Manager, Biochemical Research Loboratory-II, Eiken Chemical Co.,Ltd.

    Profile

  • Dr. Atsushi Tsuchida, Ph.D.
    Board Director, Create Vaccine Co., Ltd. and Director, Global Business Development, Sumitomo Dainippon Pharma Co., Ltd.

    Profile

18:10-19:10

Panel discussion III:

Peer into the formation of infection prevention infrastructure in Japan and collaboration with Asia, Okinawa's roles, and detailed actions

<Panelists>
  • Prof. Jiro Fujita, MD, PhD, FCCP, Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus

    Profile

  • Dr. Takashi Hirano, Ph.D. Founder and CTO, Okinawa Institute of Advanced Sciences

    Profile

  • Dr. Katsuaki Shinohara, PhD.
    Senior researcher, Division of Biosafety Control and Research, National Institute of Infectious Diseases

    Profile

<Moderator>

Dr. Masato Tashiro, MD, PhD, Former Director, Influenza Virus Research Center,
National Institute of Infectious Diseases

Profile

<Discussants>
  • H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR

  • Dr. George Fu Gao, DPhil, MSc Institute of Microbiology, Chinese Academy of Sciences China CDC

  • Dr. Supamit Chunsuttiwat, Department of Disease Control, Ministry of Public Health, Thailand

  • Dr. Srihadi Agungpriyono, DVM, PhD, Dean Faculty of Veterinary Medicine, Bogor Agricultural University (IPB), Indonesia

    Profile

  • Dr. Mohamad Subuh MPPM,
    Director General
    Directorate General Of Disease Control and Environment Health Department Minister Of Health, Republic of Indonesia

    Profile

  • Dr. Sreng Bun, Deputy-Director Department of Communicable Disease Control Ministry of Health, Cambodia

    Profile

  • Dr. Hajime Inoue, MD, MPH,
    Director, Infectious Control Division, Ministry of Health, Labour and Welfare

    Profile

19:20-21:00

Reception party

January 17 (Sat) 2015

8:30

Doors open

9:00-9:20

Special Lecture

The Ebola Crisis : Japan's Immediate Action and Mid - & Long -Term Strategy - Recommendations from The LDP -

Mr. Keizo Takemi, Liberal Democratic Party, Chair of Special Mission Committee on Global Health, Member, the House of Councilors

Profile

9:20-9:40

Keynote speech (5):

"New Initiave for Medical Research and Development in Japan"

Mr. Yutaka Hishiyama, Deputy Director-General, Office of Healthcare Policy, Cabinet Secretariat

Profile

9:40-11:10

Panel discussion IV-1<<Ebola measures>>

What actions are required for measures against Asian and global communicable diseases?

<Panelists>
  • Dr. Yasuhiro Suzuki MD PhD, Assistant Minister for Technical Affairs Minister's Secretariat, Ministry of Health, Labour and Welfare

    Profile

  • Dr. Nobuko Kurosaki MD, President of Specified Nonprofit Corporation Medecins Sans Frontieres (MSF) Japon

    Profile

  • Dr. Yasuyuki Kato, MD, MPH
    Chief of Devision of Preparedness and Emerging Infections, Disease Control and Prevention Center, National Center for Global Health and Medicine

    Profile

<Moderator>

Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization

Profile

<Discussants>
  • H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR

  • Dr. George Fu Gao, DPhil, MSc Institute of Microbiology, Chinese Academy of Sciences China CDC

  • Dr. Supamit Chunsuttiwat, Department of Disease Control, Ministry of Public Health, Thailand

  • Dr. Srihadi Agungpriyono, DVM, PhD, Dean Faculty of Veterinary Medicine, Bogor Agricultural University (IPB), Indonesia

    Profile

  • Dr. Sreng Bun, Deputy-Director Department of Communicable Disease Control Ministry of Health, Cambodia

    Profile

  • Dr. Yasuhiro Yasutomi, DVM, PhD, Director, Tsukuba Primate Research Center, Professor, Dept. of Mol. Exp. Med. National Institute of Biomedical InnovationMie University Graduate School of Medicine

    Profile

  • Mr. Yutaka Hishiyama, Deputy Director-General, Office of Healthcare Policy, Cabinet Secretariat

    Profile

  • Dr. Tatsuya Kondo, Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)

    Profile

  • Prof. Hitoshi Oshitani, MD, PhD, Tohoku University Graduate School of Medicine Department of Virology

    Profile

  • Mr. Yuzo Toda
    Director, Senior Vice president
    FUJIFILM Corporation

  • Dr. Mercy Ahun
    Special Representative for GAVI Eligible Countries

    Profile

  • Mr. Yoshiharu Yoneyama
    Deputy Director General, and Group Director for Health 1, Human Development Department, Japan International Cooperation Agency

  • Dr. BT Slingsby, MD, PhD, MPH
    Chief Executive Officer, Global Health Innovative Technology Fund

    Profile

11:10-12:10

Panel discussion IV-2:<<Ebola measures>>

Development of a detailed roadmap for IV-1

<Moderator>

Mitsuru Miyata, Executive Leader Writer, Nikkei Business Publications, Inc.

Profile

<Discussants>
  • H.E, Prof. Eksavang Vongvichit, Minister for Health of Lao PDR

  • Dr. George Fu Gao, DPhil, MSc Institute of Microbiology, Chinese Academy of Sciences China CDC

  • Dr. Supamit Chunsuttiwat, Department of Disease Control, Ministry of Public Health, Thailand

  • Dr. Srihadi Agungpriyono, DVM, PhD, Dean Faculty of Veterinary Medicine, Bogor Agricultural University (IPB), Indonesia

    Profile

  • Dr. Sreng Bun, Deputy-Director Department of Communicable Disease Control Ministry of Health, Cambodia

    Profile

  • Prof. Kimiyasu Shiraki, MD, PhD. Professor and Chairman Department of Virology, University of Toyama

    Profile

  • Dr. Yasuhiro Suzuki MD PhD, Assistant Minister for Technical Affairs Minister's Secretariat, Ministry of Health, Labour and Welfare

    Profile

  • Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization

    Profile

  • Dr. Tatsuya Kondo, Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)

    Profile

  • Prof. Hitoshi Oshitani, MD, PhD, Tohoku University Graduate School of Medicine Department of Virology

    Profile

  • Mr. Yuzo Toda
    Director, Senior Vice president
    FUJIFILM Corporation

  • Dr. Nobuko Kurosaki MD, President of Specified Nonprofit Corporation Medecins Sans Frontieres (MSF) Japon

    Profile

  • Dr. Yasuyuki Kato, MD, MPH
    Chief of Devision of Preparedness and Emerging Infections, Disease Control and Prevention Center, National Center for Global Health and Medicine

    Profile

  • Dr. BT Slingsby, MD, PhD, MPH
    Chief Executive Officer, Global Health Innovative Technology Fund

    Profile

12:10-12:40

The Nikkei Business Daily Editor in Chief Interview (Refreshments)

  • Mr. Yuzo Toda
    Director, Senior Vice president
    FUJIFILM Corporation

  • Yoichi Shinohara
    Editor-in-Chief, Nikkei Business Daily

    Profile

12:40-14:20

Final Plenary Session

Reports from the panel discussion and sectional meetings, discussion summary

<Panelists>
  • Prof. Hitoshi Oshitani, MD, PhD, Tohoku University Graduate School of Medicine Department of Virology

    Profile

  • Dr. Tadao Shimao, MD, PhD, Adviser, Japan Anti-Tuberculosis Association

    Profile

  • Dr. Yasuhiro Yasutomi, DVM, PhD, Director, Tsukuba Primate Research Center, Professor, Dept. of Mol. Exp. Med. National Institute of Biomedical InnovationMie University Graduate School of Medicine

    Profile

  • Dr. Masato Tashiro, MD, PhD, Former Director, Influenza Virus Research Center,
    National Institute of Infectious Diseases

    Profile

  • Mitsuru Miyata, Executive Leader Writer, Nikkei Business Publications, Inc.

    Profile

  • Dr. Norihito Ueda, MD, Ph.D.
    Senior Director, Vaccine Business Strategy Department, Daiichi Sankyo (DS) & Head of R&D Division, Kitasato Daiichi Sankyo Vaccine (KDSV)

    Profile

  • Prof. Jiro Fujita, MD, PhD, FCCP, Department of Infectious, Respiratory, and Digestive Medicine, Faculty of Medicine, University of the Ryukyus

    Profile

  • Mr. Yoshiharu Yoneyama
    Deputy Director General, and Group Director for Health 1, Human Development, Department, Japan International Cooperation Agency

    Profile

<Moderators>
  • Dr. Shigeru Omi, MD, PhD, President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific

    Profile

  • Dr. Nikki Shindo, MD, PhD, Team Lead, Chemical Management, Department of Pandemic and Epidemic Diseases(PED), Health Security(HSE), World Health Organization

    Profile

14:20-14:30

General Overview

Dr. Kiyoshi Kurokawa
Adjunet National Graduate Institute for Policy Studies
Chairman, Health and Global Policy Institute

14:30

Close

application form was closed.

Secretariat office for:

the 2nd Nikkei Asian Communicable Diseases Conference
PCO Works, Inc.
2F., Kanda Urban Bldg., 2-4-2 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-0048 JAPAN
E-mail: bpsemi_150116@pcoworks.jp
Tel: +81-3-6869-0713, Fax: +81-3-3291-3635